Case StudyDataNeuroSupporting payer adoption with real-world evidence: Nalu Medical demonstrates value with OM1 dataRead more
BlogRegistriesDataOtherFDA Draft Guidance Signals a New Era for Post-Approval Data in Cell & Gene TherapyRead more
PublicationDataRheumPredictors of Low Disease Activity/ Remission Amongst Rheumatoid Arthritis Patients Experiencing Inadequate Response to Biologic/ Targeted Synthetic Disease-Modifying Antirheumatic DrugsDownload
PublicationDataRheumDisease Activity in Rheumatoid Arthritis Patients Initiating Anti-Obesity Medication in a Longitudinal US-Based Real-World CohortDownload
PublicationDataRheumImpact of Change in Biologic Disease Modifying Antirheumatic Drug Therapy on Disease Activity Measures: Findings from a Large Contemporaneous Real-World Longitudinal Database of Psoriatic Arthritis PatientsDownload
PublicationDataRheumImpact of Change in Biologic Disease Modifying Antirheumatic Drug Therapy on Disease Activity Measures: Findings from a Large Contemporaneous Real-World Longitudinal Database of Rheumatoid Arthritis PatientsDownload
PublicationDataRheumCharacterization of Non-radiographic Axial Spondyloarthritis Patients and the Burden of Disease in Routine Clinical PracticeDownload
PublicationDataRheumEffect of Patient Reported Outcomes on Changes in DMARD Therapy Among Rheumatoid Arthritis Patients Treated in Routine Clinical PracticeDownload
PublicationDataRheumA Cross-Sectional Study of Rheumatoid Arthritis (RA) Diagnoses in Patients with Systemic Lupus Erythematosus (SLE)Download
PublicationDataRheumCharacterizing Non-Response to Methotrexate Monotherapy Among Rheumatoid Arthritis Patients in a Large Real-World Longitudinal CohortDownload
PublicationDataRheumPatient Characteristics and Outcomes in Patients with Rheumatoid Arthritis Treated with Upadacitinib: The OM1 RA RegistryDownload
PublicationAIDataRheumPrediction of Non-Response to First-Line Methotrexate Treatment in Rheumatoid Arthritis: A Real-World Data Analysis Using Machine LearningDownload
PublicationAIDataRheumValidation of a Machine Learning Approach to Estimate Systemic Lupus Erythematosus Disease Activity Index Score Categories and Application in a Real-World DatasetDownload
PublicationDataRheumHarmonized Outcome Measures for Use in Degenerative Lumbar Spondylolisthesis Patient Registries and Clinical PracticeRead more
PublicationDataRheumCharacterizing Patients Initiating Abaloparatide, Teriparatide, or Denosumab in a Real-World Setting: a US Linked Claims and EMR Database AnalysisDownload
PublicationDataRheumAn Evaluation of Real-World Use of Biologics in Rare Systemic Vasculitides During Routine Clinical Care in the USDownload
PublicationDataRheumAssessing Comorbid Inflammatory Arthritis Conditions and Swollen to Tender Joint Count Ratios in a Real-World Systemic Lupus Erythematosus CohortDownload
PublicationDataRheumJoint Involvement and Disease Activity in Systemic Lupus Erythematosus (SLE) Patients: Calculation of Swollen to Tender Joint Count Ratio in a Real-World Cohort in the U.S.Download
PublicationDataRheumPredictors of Improvement in Tender Joint Counts Among Patients with Systemic Lupus Erythematosus in A Large, Representative US-Based Real-World Registry Cohort. ISPOR Annual Conference. Orlando, FL, May 2020.Download
PublicationDataRheumCharacteristics and Disease Management in a Large Real-World Lupus Nephritis Cohort in the U.S.Download
PublicationDataRheumPatient Characteristics and Management Of Juvenile Idiopathic Arthritis (JIA) In a Large, Representative Real-World CohortDownload
PublicationDataRheumAvailability of Disease Activity Measures from Systemic Lupus Erythematosus Patients in a Large, Representative US-Based Real World Registry CohortDownload
PublicationDataRheumImprovements in Disease Activity Scores Associated with bDMARD use by Rheumatoid Arthritis Patients in a Large US-Based Real World CohortDownload
PublicationDataRheumPatient Characteristics and Current Management of Systemic Lupus Erythematosus Patients in a Large, Representative US-Based Real World CohortDownload
PublicationDataRheumAge and Gender Differences in Comorbidities among Patients with Rheumatoid Arthritis in a Large US-Based Real World CohorDownload
PublicationDataRheumTreatment Patterns in Large Vessel Arteritis (Giant Cell Arteritis and Temporal Arteritis): Findings from a Large Contemporaneous Real-World Cohort in the U.S.Download
PublicationDataRheumInitiation of Biologic Disease Modifying Antirheumatic Drug Therapy and Associated Changes in Disease Activity Measures in Routine Clinical Practice: Findings from a Large Contemporaneous Real World CohortDownload
PublicationDataRheumComparison of Improvements in Disease Activity between Classes of Biologic Disease Modifying Anti-Rheumatic Drugs in Routine Clinical Practice: Findings from a Large Contemporaneous Real World CohortRead more
PublicationDataRheumInitiation of Biologic Disease Modifying Antirheumatic Drug Therapy and Associated Changes in Disease Activity Measures in Routine Clinical Practice: Findings from a Next Generation RegistryDownload
PublicationDataRheumPatient Reported Outcomes and Changes in DMARD Therapy for Rheumatoid Arthritis in Routine Clinical PracticeDownload
PublicationDataMental HealthSuicidal Ideation in Patients Treated with Glucagon-like Peptide 1 Receptor (GLP1) Agonists: A Retrospective Real-World AnalysisDownload
PublicationDataMental Healthhe Association Between Adherence to Esketamine Nasal Spray Therapy Dosing Regimen and Changes in Depressive Symptoms Among Patients With Treatment-Resistant Depression in the U.S.Download
PublicationDataMental HealthAddressing Gaps in Real-World Data Sources through Automated Extraction of Psychiatric Comorbidities and Medication Side Effects from Clinical NotesDownload
PublicationDataMental HealthThe Association Between Race, Social Determinants of Health, and Treatment for Major Depressive Disorder (MDD) in a Real-World CohortDownload
PublicationDataMental HealthChanges in Weight Across the Life Span in Patients with Bipolar Disorder I Treated with Second Generation AntipsychoticsDownload
PublicationDataMental HealthWeight Gain and Treatment Interruptions With Second-Generation Oral Antipsychotics: Analysis of Real-World Data Among Patients With Schizophrenia or Bipolar I DisorderDownload
PublicationDataMental HealthEvaluating the Feasibility of Capturing a Core Set of Harmonized Depression Outcome Measures in Primary Care and Mental Health Patient RegistriesDownload
PublicationDataMental HealthDepression and Patient Outcomes Among Rheumatoid Arthritis Patients in a Large US-Based Real World CohortDownload
PublicationDataMental HealthPatient & Provider Characteristics Associated with PHQ-9 Administration and Outcomes Assessment in Routine Clinical Practice: Findings from the OM1 Intelligent Data CloudDownload
PublicationDataNeuroAssessing the Expanded Disability Status Scale in Secondary Progressive Multiple Sclerosis Patients Treated with Disease Modifying Therapies within a Large, Representative Real World Multiple Sclerosis RegistryDownload
PublicationDataNeuroAssessing Comorbid Behavioral Health Conditions, Healthcare Resource Utilization, and Medication Use in Patients Seeking Mental Health Care within a Large, Representative Real-World Multiple Sclerosis RegistryDownload
PublicationDataNeuroComparison of Symptoms, Treatments, and Healthcare Resource Utilization in Patients with Multiple Sclerosis by Sex in a Real-World Cohort in the U.S.Download
PublicationDataNeuroA Real-World Retrospective Analysis of Outcomes in Multiple Sclerosis Patients Who Transitioned to Alemtuzumab After Rituximab or OcrelizumabDownload
PublicationDataNeuroTreatment Patterns and Reasons for Switching among U.S. Patients with Multiple Sclerosis Taking the Glatiramer Acetate Class of ProductsDownload
PublicationDataNeuroRevisiting MS Prevalence in the 21st Century: Exploration Based on a Large Representative US-Based Real-World CohortDownload
PublicationDataNeuroReal-World Switching Patterns Among US Generic Glatiramer Acetate Multiple Sclerosis PatientsDownload
PublicationDataCardioThe Association Between Social Determinants of Health and 1-Year Survival Among Patients with Heart Failure in a Real-World CohortDownload
PublicationDataCardioVariation in Outcome Measures in Atrial Fibrillation Registries and the Need for HarmonizationDownload
PublicationDataDermDiabetes and obesity burden and improvements in cardiometabolic parameters in patients with psoriasis or psoriatic arthritis receiving apremilast in a real-world setting.Download
PublicationDataDermReal-World Dupilumab Continuation in US Children and Adolescents With Atopic Dermatitis Over a 24-Month PeriodDownload
PublicationDataDermPatient Characteristics and Social Determinants of Health in a Large Real-World Cohort of Vitiligo Patients in the U.S.Download
PublicationDataDermReal-World Characterization and Management of Alopecia Areata Patients in the U.S.Download
PublicationDataDermPatient-Reported Outcomes and Changes in DMARD Therapy Among Psoriatic Arthritis Patients Treated in Routine Clinical Practice.Download
PublicationDataDermComparison of Improvements in Psoriatic Arthritis Disease Activity between Classes of Biologic Disease Modifying Anti-Rheumatic Drugs in Routine Clinical PracticeDownload
PublicationDataDermCharacterization of Patients with Co-morbid Dermatological and Mental Health ConditionsDownload
PublicationDataDermReal-World Use of Biologics and Prescription Topical Medications in Pediatric Psoriasis in a Large Dermatology Network in the U.S.Download
PublicationDataRespiratoryHarmonized Outcome Measures for Use in Asthma Patient Registries and Clinical PracticeDownload
PublicationDataGastroMethod To Derive A Crohn’s Disease Activity Index From Electronic Health Records DataDownload
PublicationDataOncologyImpact of Population Characteristic on Recall Rates: Initial Finding from a Learning Health SystemDownload
PublicationDataCardioDefining Provider Prescribing Preference as an Instrumental Variable: A Case Study of NOACs in Stroke PreventionDownload
PublicationDataCardioCharacteristics of Asymptomatic Heart Failure Patients with Reduced Ejection Fraction in a Large US-Based Real-World CohortDownload
PublicationDataDermReal-World Dupilumab Continuation in US Adults With Atopic Dermatitis Over a 24-Month PeriodDownload
PublicationDataDermNatural History of Keloids: A Sociodemographic Analysis Using Structured and Unstructured DataRead more
PublicationDataDermA Real World Analysis of Apremilast and Cardiometabolic Comorbidities in Psoriasis and Psoriatic Arthritis, Including Impact on Weight Loss by Diabetic StatusDownload
PublicationDataDermTreatment Supplementation Following Dupilumab Initiation in Real-World Patients With Atopic Dermatitis in the U.S.Download
PublicationDataGastroMethod to Derive a Modified Mayo Score from Electronic Health Records DataDownload
PublicationRegistriesDataOncologyDisparities in Accessing Screening Mammography: Opportunities for Improving Diagnostic OutcomesDownload
PublicationDataMental HealthReductions in Depressive Symptoms After Brexpiprazole Augmentation Among Patients with Major Depressive Disorder Receiving Antidepressant Therapy in Real-World SettingsDownload
PublicationDataMental HealthHarmonized Outcome Measures for Use in Depression Patient Registries and Clinical PracticesDownload
PublicationDataNeuroDiagnosis of Frontotemporal Dementia is Often in Non-Specialist Settings and Complicated by Non-FTD Dementia and Psychiatric DiagnosesDownload
PublicationDataNeuroUsing Real-World Data and Digital Phenotyping to Identify Candidates for anti-CGRP Migraine TreatmentDownload
PublicationDataOncologyRepresentation of patients of minority race and ethnicity in real-world databases and tumor registries of patients with breast cancerDownload
PublicationDataOncologyHarmonized Outcome Measures for Use in Non–Small Cell Lung Cancer Patient Registries and Clinical PracticeDownload
PublicationDataRegistriesOtherAssessing Real-World Data Quality: The Application of Patient Registry Quality Criteria to Real-World Data and Real-World EvidenceDownload
PublicationDataOtherImpact of New Guidelines for High Blood Pressure: Findings from the OM1 Intelligent Data CloudDownload
PublicationDataMental HealthClinical burden of major depressive disorder with versus without prominent anhedonia using a real-world electronic health records and claims linked databaseDownload
PublicationDataMental HealthReal-world effectiveness of cariprazine in major depressive disorder and bipolar I disorder in the United StatesRead more
PublicationDataMental HealthWeight Gain and Comorbidities Associated With Oral Second-Generation Antipsychotics: Analysis of Real-World Data for Patients With Bipolar I Disorder or SchizophreniaDownload
PublicationDataNeuroReal-world healthcare utilization and costs of peripheral nerve stimulation with a micro-IPG systemDownload
PublicationDataCardioHarmonized Outcome Measures for Use in Atrial Fibrillation Patient Registries and Clinical PracticeDownload
PublicationDataCardioStandardized Library of Atrial Fibrillation Outcome Measures. Research White Paper.Download
PublicationDataRespiratoryReduction in healthcare resource use through 24 months following sinus surgery with steroid-eluting implants in chronic rhinosinusitis patients with and without nasal polyps: a real-world studyDownload
PublicationDataRespiratoryReal-World Evidence Analysis of the Impact of Steroid-Eluting Implants on Healthcare Resource Use Among Chronic Rhinosinusitis Patients Undergoing Sinus SurgeryDownload
PublicationRegistriesDataOncologyComparison of Resource Utilization and Clinical Outcomes Following Screening with Digital Breast Tomosynthesis Versus Digital Mammography: Findings From a Learning Health SystemDownload
Webinar & VideoAIDataRheumFrom Subtyping to Measuring and Predicting Outcomes: How AI is Changing Rheumatology and Immunology ResearchRead more
News & ArticleDataNeuroOM1 expands neurology network to over 3 million patients for real-world data researchRead more
News & ArticleDataNeuroOM1 Adds a Half Million Patients to Neurology Network, Strengthening Real-World Evidence Generation and Accelerating Innovation in NeurologyRead more
Webinar & VideoDataRheumBehind the Insights: Ep 05 Rheumatoid Arthritis Remission with Chandra Gopalakrishnan, MD, MPHRead more
News & ArticleDataCardioMental HealthOM1 to Present Groundbreaking Research on GLP-1 Agonists and Suicidal Ideation at ISPOR 2025.Read more
News & ArticleDataMental HealthOM1 to Present Groundbreaking Research on GLP-1 Agonists and Suicidal Ideation at ISPOR 2025Read more
News & ArticleDataMental HealthOM1 expands mental health network to over six million patients, enhancing real-world evidence and personalized care capabilitiesRead more
News & ArticleDataMental HealthOM1 Adds 1 Million Patients to Its Mental Health Network, Significantly Expanding Specialty Coverage and Driving New Possibilities for Real-World Research and Personalized CareRead more
News & ArticleDataNeuroNalu PNS System Significantly Reduces Healthcare-Related Costs in Chronic Pain PatientsRead more
News & ArticleDataMental HealthMDMA Therapy for Mental Health Conditions: Do the Benefits Outweigh the Risks?Read more
News & ArticleDataAINeuroQ&A: New Alzheimer’s dataset allows ‘whispers from the brain’ to assist in early detectionRead more
News & ArticleAIRegistriesDataOM1 Earns Frost & Sullivan's 2024 North American New Product Innovation Award for Transforming Real-world Evidence Analytics Solutions Industry with Its Pioneering AI-powered PlatformsRead more
News & ArticleDataPanalgo and OM1 Expand Partnership to Offer OM1's PremiOM Datasets in Panalgo's IHD Analytics PlatformRead more
News & ArticleDataOtherOM1 and Medtronic Partner on Propel Study to Assess Long-term Outcomes for Patients With Chronic RhinosinusitisRead more
News & ArticleDataWomen in Science: Kathryn Starzyk on the power and complexities of real-world evidenceRead more
News & ArticleDataDermStefan Weiss, MD, Discusses OM1’s New HS Dataset and Expanded Dermatology NetworkRead more
News & ArticleDataRespiratoryOM1 Launches Asthma and Chronic Rhinosinusitis Datasets to Expand RWERead more
News & ArticleDataRespiratoryOM1 Launches Asthma and Chronic Rhinosinusitis Datasets to Expand Real-World Evidence in Respiratory and ENTRead more
News & ArticleDataDermOM1 Launches HS Dataset to Expand Use of Real-World Evidence in DermatologyRead more
News & ArticleDataDermOM1 Launches Hidradenitis Suppurativa Dataset to Expand Real-World Evidence in DermatologyRead more
News & ArticleDataNeuroOM1 Launches Parkinson’s Disease Premium Dataset to Expand Real-World Evidence in NeuroscienceRead more
News & ArticleDataMental HealthEXPERT PRAISES PROPOSED FEDERAL RULE TO STRENGTHEN BEHAVIORAL HEALTH PARITYRead more
News & ArticleDataDermUnderstanding How Data Analytics Help Improve Health Outcomes With Stefan Weiss, MDRead more
News & ArticleDataMental HealthHow Real-World Data Can Contribute to Improved Mental Health TreatmentRead more
News & ArticleDataMental HealthOM1 Launches Analytics to Deliver Mental Health & Immunology Insights on Prescriber Trends and Therapy EffectivenessRead more
News & ArticleDataAIRheumAmplifying lupus disease activity with real-world data and machine learningRead more
News & ArticleDataAIRheumRAPID3 Scores May Help Determine the Impact of DMARD Therapy on PsA SeverityRead more
News & ArticleAIDataDermDermatology Data Can Direct Policy Priorities, but Gaps Reflect Inequities of CareRead more
News & ArticleDataClinical investigators need to be wary of confounding and bias in real-world studies; here is what to look for and how to address itRead more
News & ArticleDataMental HealthOM1 Expands Mental Health Offering With Real-World Datasets Including Schizophrenia and Bipolar DisorderRead more
News & ArticleDataOM1 Launches Analytic Reports Uncovering Causes of Medication Discontinuation in Immunology PatientsRead more
News & ArticleDataRheumKazuki Yoshida, MD, MPH, ScD: Methotrexate Access in the Post-Roe v Wade EraRead more
News & ArticleDataHow’d They Do It? Tech Leaders Reflect on How They Innovated To Solve Health ProblemsRead more
News & ArticleDataMental HealthReal-World Data Delivers Dose of Hope for Mental Health in the U.S.Read more
News & ArticleDataNeuroOM1 Launches Multiple Sclerosis Registry with More than 20,000 Patients Prospectively Followed with Deep Clinical DataRead more
News & ArticleDataRheumOM1 Rheumatoid Arthritis Registry Reaches More Than 200,000 Patients Prospectively Followed With Deep Clinical DataRead more
News & ArticleAIDataDermAmerican Academy Of Dermatology Collaborates With OM1 To Empower More Measured & Precise Care And Treatments For DermatologyRead more
News & ArticleDataCardioOM1 Heart Failure Registry Reaches More than 140,000 Patients Prospectively Followed with Deep Clinical DataRead more
News & ArticleDataRheumOM1 Giant Cell Arteritis Registry Reaches More Than 5,000 Patients Prospectively Followed With Deep Clinical DataRead more
News & ArticleDataRheumOM1 Rheumatoid Arthritis Registry Reaches More Than 100,000 Patients Prospectively Followed with Deep Clinical DataRead more
News & ArticleRegistriesDataCardioNew Harmonized Outcome Measures for Atrial Fibrillation Published in HeartRhythmRead more
![PM360 asked for companies to send in their latest and best ways to improve adherence. Here are twelve of the best examples of programs, strategies, solutions, technology, and more that companies have developed or are using to keep patients on their prescribed therapies. [tab: BrightInsight] PSP+ Companion App BrightInsight Jamie…](/_next/image/?url=https%3A%2F%2Fimages.ctfassets.net%2Fddhe5ahaolzf%2F6LdVlJlgTWUIWLOiY9S9of%2F42ca205e7a66f7b202124fcefe81b471%2FFocus-On-New-Adherence-Solutions-0723.jpg&w=3840&q=75)
